Literature DB >> 32202659

Coronavirus disease 2019: the harms of exaggerated information and non-evidence-based measures.

John P A Ioannidis1.   

Abstract

The evolving coronavirus disease 2019 (COVID-19) pandemic1 is certainly cause for concern. Proper communication and optimal decision-making is an ongoing challenge, as data evolve. The challenge is compounded, however, by exaggerated information. This can lead to inappropriate actions. It is important to differentiate promptly the true epidemic from an epidemic of false claims and potentially harmful actions. This article is protected by copyright. All rights reserved.

Entities:  

Year:  2020        PMID: 32202659     DOI: 10.1111/eci.13223

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  22 in total

1.  Scientific quality of COVID-19 and SARS CoV-2 publications in the highest impact medical journals during the early phase of the pandemic: A case control study.

Authors:  Marko Zdravkovic; Joana Berger-Estilita; Bogdan Zdravkovic; David Berger
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

2.  Redundancy in reporting on COVID-19.

Authors:  Dino Papes; Elizabeta Ozimec
Journal:  Eur J Clin Invest       Date:  2020-05-18       Impact factor: 4.686

3.  COVID-19: science must not be the boy who cried wolf.

Authors:  Philip Lewis; Thomas C Erren
Journal:  J Epidemiol Community Health       Date:  2020-05-20       Impact factor: 3.710

4.  Assessing the reading level of online resources on COVID-19.

Authors:  Lee Treanor; Aleksandar Radonjic
Journal:  Can J Public Health       Date:  2020-06-25

5.  How psychosocial and economic impacts of COVID-19 pandemic can interfere on bruxism and temporomandibular disorders?

Authors:  Camila Megale Almeida-Leite; Juliana Stuginski-Barbosa; Paulo César Rodrigues Conti
Journal:  J Appl Oral Sci       Date:  2020-05-11       Impact factor: 2.698

6.  Letter to the Editor Re: Coronavirus disease 2019: The harms of exaggerated information and non-evidence-based measures.

Authors:  Giovanni Gabutti
Journal:  Eur J Clin Invest       Date:  2020-05-24       Impact factor: 4.686

7.  Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators.

Authors:  H Keipp Talbot; Emily T Martin; Manjusha Gaglani; Donald B Middleton; Shekhar Ghamande; Fernanda P Silveira; Kempapura Murthy; Richard K Zimmerman; Christopher H Trabue; Samantha M Olson; Joshua G Petrie; Jill M Ferdinands; Manish M Patel; Arnold S Monto
Journal:  Clin Infect Dis       Date:  2021-12-16       Impact factor: 9.079

8.  COVID-19, internists and resilience: the north-south Italy outbreak.

Authors:  Agostino Di Ciaula; Vincenzo O Palmieri; Giovanni Migliore; Piero Portincasa
Journal:  Eur J Clin Invest       Date:  2020-06-29       Impact factor: 5.722

9.  SARS-CoV-2 outbreak and lockdown in a Northern Italy hospital. Comparison with Scandinavian no-lockdown country.

Authors:  Federico Carbone; Fabrizio Montecucco
Journal:  Eur J Clin Invest       Date:  2020-06-07       Impact factor: 5.722

10.  SARS-CoV-2: What is known and what there is to know-Focus on coagulation and lipids.

Authors:  Federico Carbone; Fabrizio Montecucco; Marcel Twickler
Journal:  Eur J Clin Invest       Date:  2020-06-25       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.